Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothée Lenglet

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
European Journal of Neurology|May 28, 2026
Bevacizumab for Radiation-Induced (Radiculo)plexopathyAlberto Picca, Timothée Lenglet, Christophe Vandendries, et al.
Journal of the Peripheral Nervous System : JPNS|May 5, 2020
Motor chronic inflammatory demyelinating polyneuropathy (CIDP) in 17 patients: Clinical characteristics, electrophysiological study, and response to treatmentAntoine Pegat, William Boisseau, Thierry Maisonobe, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 7, 2013
Chronic inflammatory demyelinating polyradiculoneuropathy: search for factors associated with treatment dependence or successful withdrawalMagalie Rabin, Gurkam Mutlu, Tanya Stojkovic, et al.
BMJ Open|January 16, 2026
Safety and efficacy of the Atalante exoskeleton in the rehabilitation of French patients with amyotrophic lateral sclerosis: a prospective, monocentric, open, uncontrolled, interventional protocol, EXALSGhida Trad, Timothée Lenglet, Isabelle Ledoux, et al.
Scientific Reports|April 23, 2026
Exploring the interplay between quantitative muscle strength, functional performance, and patient-reported outcomes in amyotrophic lateral sclerosis: a cross-sectional pilot studyGhida Trad, Timothée Lenglet, Isabelle Ledoux, et al.
Journal of Neuroengineering and Rehabilitation|July 2, 2026
Safety, feasibility and preliminary effects of Atalante exoskeleton-assisted gait training in amyotrophic lateral sclerosis: a prospective ABA pilot studyGhida Trad, Timothée Lenglet, Isabelle Ledoux, et al.
Journal of Neurology|May 5, 2018
Motor neuron disease of paraneoplastic origin: a rare but treatable conditionNicolas Mélé, Giulia Berzero, Thierry Maisonobe, et al.
Journal of the Peripheral Nervous System : JPNS|April 3, 2012
Heterogeneous spectrum of neuropathies in Waldenström's macroglobulinemia: a diagnostic strategy to optimize their managementKarine Viala, Tanya Stojkovic, Anne-Violaine Doncker, et al.
Annals of Clinical and Translational Neurology|February 6, 2020
A juvenile ALS-like phenotype dramatically improved after high-dose riboflavin treatmentChristophe Carreau, Timothée Lenglet, Isabelle Mosnier, et al.
British Journal of Clinical Pharmacology|August 26, 2022
Peripheral neuropathies after BRAF and/or MEK inhibitor treatment: A pharmacovigilance studyAlberto Picca, Cristina Birzu, Giulia Berzero, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
European Journal of Neurology|May 28, 2026
Bevacizumab for Radiation-Induced (Radiculo)plexopathyAlberto Picca, Timothée Lenglet, Christophe Vandendries, et al.
Journal of the Peripheral Nervous System : JPNS|May 5, 2020
Motor chronic inflammatory demyelinating polyneuropathy (CIDP) in 17 patients: Clinical characteristics, electrophysiological study, and response to treatmentAntoine Pegat, William Boisseau, Thierry Maisonobe, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 7, 2013
Chronic inflammatory demyelinating polyradiculoneuropathy: search for factors associated with treatment dependence or successful withdrawalMagalie Rabin, Gurkam Mutlu, Tanya Stojkovic, et al.
BMJ Open|January 16, 2026
Safety and efficacy of the Atalante exoskeleton in the rehabilitation of French patients with amyotrophic lateral sclerosis: a prospective, monocentric, open, uncontrolled, interventional protocol, EXALSGhida Trad, Timothée Lenglet, Isabelle Ledoux, et al.
Scientific Reports|April 23, 2026
Exploring the interplay between quantitative muscle strength, functional performance, and patient-reported outcomes in amyotrophic lateral sclerosis: a cross-sectional pilot studyGhida Trad, Timothée Lenglet, Isabelle Ledoux, et al.
Journal of Neuroengineering and Rehabilitation|July 2, 2026
Safety, feasibility and preliminary effects of Atalante exoskeleton-assisted gait training in amyotrophic lateral sclerosis: a prospective ABA pilot studyGhida Trad, Timothée Lenglet, Isabelle Ledoux, et al.
Journal of Neurology|May 5, 2018
Motor neuron disease of paraneoplastic origin: a rare but treatable conditionNicolas Mélé, Giulia Berzero, Thierry Maisonobe, et al.
Journal of the Peripheral Nervous System : JPNS|April 3, 2012
Heterogeneous spectrum of neuropathies in Waldenström's macroglobulinemia: a diagnostic strategy to optimize their managementKarine Viala, Tanya Stojkovic, Anne-Violaine Doncker, et al.
Annals of Clinical and Translational Neurology|February 6, 2020
A juvenile ALS-like phenotype dramatically improved after high-dose riboflavin treatmentChristophe Carreau, Timothée Lenglet, Isabelle Mosnier, et al.
British Journal of Clinical Pharmacology|August 26, 2022
Peripheral neuropathies after BRAF and/or MEK inhibitor treatment: A pharmacovigilance studyAlberto Picca, Cristina Birzu, Giulia Berzero, et al.
Pageof 6